- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT05174117
Influence of Different Light Dose on the Adverse Effect of Swallowing for Esophageal Carcinoma
A Phase III Randomized Controlled Study of the Effect of Different Light Doses on Adverse Outcomes of Swallowing in Esophageal Cancer
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Background: Photodynamic therapy (PDT) is one of the effective means for the control of esophageal stenosis in advanced esophageal cancer, among which the dose intensity of laser irradiation is one of the factors affecting the efficacy. This study aims to pursue the appropriate dose of light.
Aim: To compare the efficacy and safety of two groups of different laser irradiation doses for advanced esophageal cancer and esophageal stricture.
Methods: Fifty-seven patients were recruited for this study and randomly divided into two groups: single irradiation group and reirradiation group.Single irradiation group: 46-48h irradiation after photosensitizer injection: power density: 200mW·cm-2, irradiation time: 900s, volume density: 180 J·cm-2;Double irradiation group: 46-48h, 72h after photosensitizer injection, divided into two irradiation times: power density: 200mW·cm-2, irradiation time: 900s, volume density: 180 J·cm-2;Power density: 200mW·cm-2, irradiation time: 300s, volume density: 60 J·cm-2.
Primary endpoints: ORR rates at 1 and 3 months, the quality of life
Undersøgelsestype
Tilmelding (Forventet)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Shegan Gao, MD, PhD
- Telefonnummer: 18638859977
- E-mail: gsg112258@163.com
Undersøgelse Kontakt Backup
- Navn: Tanyou Shan, MD, PhD
- Telefonnummer: 18537976669
- E-mail: shantanyoudoctor@163.com
Studiesteder
-
-
Henan
-
Luoyang, Henan, Kina, 471003
- The First Affiliated Hospital and Clinical Medicine of Henan University of Science and Technology
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- esophagus cancer
- 18-80 years old
- grade 3-4 dysphagia (Stoller classification)
- Non-eradicative second-line treatment
Exclusion Criteria:
- Ulcerative tumor
- Esophageal stenosis caused by radiotherapy
- Survival is less than 3 months
- Patients known to be allergic to photosensitizers
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: single irradiation group
46-48h irradiation after photosensitizer injection: power density: 200mW·cm-2, irradiation time: 900s, volume density: 180 J·cm-2
|
46-48h irradiation after photosensitizer injection: power density: 200mW·cm-2, irradiation time: 900s, volume density: 180 J·cm-2
|
|
Aktiv komparator: Double irradiation group
46-48h, 72h after photosensitizer injection, divided into two irradiation times: power density: 200mW·cm-2, irradiation time: 900s, volume density: 180 J·cm-2;Power density: 200mW·cm-2, irradiation time: 300s, volume density: 60 J·cm-2.
|
46-48h, 72h after photosensitizer injection, divided into two irradiation times: power density: 200mW·cm-2, irradiation time: 900s, volume density: 180 J·cm-2;Power density: 200mW·cm-2, irradiation time: 300s, volume density: 60 J·cm-2.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
1 month objective response rate
Tidsramme: 1 month after photodynamic irradiation
|
Grade 3-4 dysphagia accounted
|
1 month after photodynamic irradiation
|
|
3 month objective response rate
Tidsramme: 3 month after photodynamic irradiation
|
Grade 3-4 dysphagia accounted
|
3 month after photodynamic irradiation
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
3 month Quality of Life score
Tidsramme: 3 month after photodynamic irradiation
|
3 month after photodynamic irradiation
|
Samarbejdspartnere og efterforskere
Efterforskere
- Studiestol: Shegan Gao, MD, PhD, The First Affiliated Hospital of Clinical Medicine of Henan University of Science and Technology
- Studieleder: Tanyou Shan, MD, PhD, The First Affiliated Hospital and Clinical Medicine of Henan University of Science and Technology
- Ledende efterforsker: Caihong Dong, MD, PhD, The First Affiliated Hospital and Clinical Medicine of Henan University of Science and Technology
- Ledende efterforsker: Wanying Li, MD, The First Affiliated Hospital and Clinical Medicine of Henan University of Science and Technology
- Ledende efterforsker: Jiachun Sun, MD, PhD, The First Affiliated Hospital and Clinical Medicine of Henan University of Science and Technology
- Ledende efterforsker: Mengxi Zhang, MD, PhD, The First Affiliated Hospital and Clinical Medicine of Henan University of Science and Technology
- Ledende efterforsker: Xiaozhi Yuan, MD, PhD, The First Affiliated Hospital and Clinical Medicine of Henan University of Science and Technology
Publikationer og nyttige links
Generelle publikationer
- Zeng R, Liu C, Li L, Cai X, Chen R, Li Z. Clinical Efficacy of HiPorfin Photodynamic Therapy for Advanced Obstructive Esophageal Cancer. Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820930335. doi: 10.1177/1533033820930335.
- Yoon HY, Cheon YK, Choi HJ, Shim CS. Role of photodynamic therapy in the palliation of obstructing esophageal cancer. Korean J Intern Med. 2012 Sep;27(3):278-84. doi: 10.3904/kjim.2012.27.3.278. Epub 2012 Sep 1.
- Liu H, Liu Y, Wang L, Ruan X, Wang F, Xu D, Zhang J, Jia X, Liu D. Evaluation on Short-Term Therapeutic Effect of 2 Porphyrin Photosensitizer-Mediated Photodynamic Therapy for Esophageal Cancer. Technol Cancer Res Treat. 2019 Jan 1;18:1533033819831989. doi: 10.1177/1533033819831989.
- Lee HH, Choi MG, Hasan T. Application of photodynamic therapy in gastrointestinal disorders: an outdated or re-emerging technique? Korean J Intern Med. 2017 Jan;32(1):1-10. doi: 10.3904/kjim.2016.200. Epub 2017 Jan 1.
- Yano T, Minamide T, Takashima K, Nakajo K, Kadota T, Yoda Y. Clinical Practice of Photodynamic Therapy Using Talaporfin Sodium for Esophageal Cancer. J Clin Med. 2021 Jun 24;10(13):2785. doi: 10.3390/jcm10132785.
- National Health Commission Of The People's Republic Of China. Chinese guidelines for diagnosis and treatment of esophageal carcinoma 2018 (English version). Chin J Cancer Res. 2019 Apr;31(2):223-258. doi: 10.21147/j.issn.1000-9604.2019.02.01. No abstract available.
Datoer for undersøgelser
Studer store datoer
Studiestart (Forventet)
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- ECPDT-001
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Spiserørskræft
-
Digma Medical Ltd.Ikke rekrutterer endnu
-
Erbe Elektromedizin GmbHNAMSA; Kansas City Veteran Affairs Medical Center; Erbe USA IncorporatedAfsluttetBarretts spiserør | Højgradig dysplasi i Barrett-esophagus | Lavgradig dysplasi i Barrett-esophagusForenede Stater
-
University Medical Center GroningenIkke rekrutterer endnuBarrett Esophagus Adenocarcinom | Barrett's Esophagus With or Without DysplasiaHolland
-
Maria Sklodowska-Curie National Research Institute...Centre of Postgraduate Medical EducationAfsluttetBarretts esophagus med lavgradig dysplasi
-
Tomasz RomańczykAfsluttetHeterotopisk maveslimhinde i den proksimale esophagusPolen
-
University Medical Center GroningenAfsluttetSpiserørskræft | Barrett Esophagus | Dysplasi i Barrett EsophagusHolland
-
Johns Hopkins UniversityAmerican Society for Gastrointestinal Endoscopy; Pentax Medical CorporationAfsluttetBarretts esophagus, esophageal intraepithelial neoplasiForenede Stater, Tyskland
-
University Hospital, AntwerpKarolinska University Hospital; Karolinska Institutet; Rigshospitalet, Denmark og andre samarbejdspartnereIkke rekrutterer endnuBarrett Esophagus | Gastroenterologi | Barrett Esophagus Adenocarcinom | Adenocarcinom - GEJ | Gastroenterologisk kræftDanmark, Belgien, Sverige, Irland, Italien, Frankrig, Tyskland
-
Coordinación de Investigación en Salud, MexicoSuspenderetIntestinal Metaplasi | Dysplasi | Barretts esophagus med lavgradig dysplasiMexico
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Nederlandse Barrett REgistratie StichtingRekrutteringBarrett Esophagus | Barrett Esophagus AdenocarcinomHolland
Kliniske forsøg med single irradiation
-
Institute of Hematology and Blood Transfusion,...Proton Therapy Center Czech s.r.o.RekrutteringAkut myeloid leukæmi (AML) | Protonterapi | MDS og AML før allogen SCT | Myelodysplastisk neoplasma | Myelodysplastisk syndrom (MDS)/AMLTjekkiet
-
Sun Yat-sen UniversityRekrutteringTilbagevendende nasopharynx carcinom | Nasopharangeal kræftKina
-
The Cleveland ClinicNational Cancer Institute (NCI)AfsluttetLymfom | Myelodysplastiske syndromer | Leukæmi | Kroniske myeloproliferative lidelser | Præcancerøs/ikke-malign tilstand | Sekundær myelofibrose | Myelomatose og maligne plasmacelle-neoplasmerForenede Stater
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)Afsluttet
-
Bambino Gesù Hospital and Research InstituteIkke rekrutterer endnuStamcelletransplantation | Akut lymfatisk leukæmi (ALL) | Pode - Versus-værtssygdomTjekkiet, Italien, Østrig, Danmark, Finland, Frankrig, Tyskland, Norge, Polen
-
Nanfang Hospital of Southern Medical UniversityXiangya Hospital of Central South University; Guangzhou First People's... og andre samarbejdspartnereAfsluttetAkut lymfatisk leukæmi | Allogen hæmatopoietisk stamcelletransplantation | Busulfan | Total kropsbestrålingKina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)AfsluttetLeukæmiForenede Stater
-
Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of MedicineTrukket tilbageLymfoide hæmatologiske maligniteter | Navlestrengsblodtransplantation
-
Masonic Cancer Center, University of MinnesotaRekrutteringAkut myeloid leukæmi | Myelodysplastiske syndromer | AML | Akut leukæmi | MDSForenede Stater
-
National Cancer Institute (NCI)Ikke rekrutterer endnuLymfom | Leukæmi | Hæmatologiske neoplasmer | Core Binding Factor Alpha SubunitsForenede Stater